SourceBio International 

0
0
+€0.00+0% 00:00 今天

统计

当日最高
-
当日最低
-
52周高点
-
52周低点
-
成交量
-
平均成交量
-
市值
0
市盈率
-
股息率
-
股息
-

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。

关于

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services. It also manufactures library clones, direct to consumer home test kits, and blood and tissue serological products; and provides employee testing solutions and venue testing. In addition, the company offers controlled environment storage services and diagnostic and genomic services and products. Sourcebio International Plc was founded in 1999 and is headquartered in Nottingham, the United Kingdom.
显示更多
首席执行官
Mr. Jay Charles LeCoque
员工
339
国家
英国
ISIN
GB00BKSB1674
WKN
000A2QGNC

上市

0 条评论

分享你的想法

常见问题

SourceBio International 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 Boerse Stuttgart 交易所,SourceBio International 的股票以代码 6J8.STU 进行交易。
SourceBio International 有多少名员工?▼
截至2026年11月2日,公司共有339名员工。
SourceBio International 属于哪个行业?▼
SourceBio International从事于健康与养生行业。
SourceBio International 何时完成拆股?▼
SourceBio International 最近没有进行任何拆股。
SourceBio International 的总部在哪里?▼
SourceBio International 的总部位于 英国 的 Nottingham。